Vanda Pharmaceuticals Inc. Logo

Vanda Pharmaceuticals Inc.

Develops and commercializes innovative therapies for central nervous system disorders.

VNDA | US

Overview

Corporate Details

ISIN(s):
US9216591084
LEI:
Country:
United States of America
Address:
2200 PENNSYLVANIA AVE NW, 20037 WASHINGTON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs. The company's mission is to improve the lives of patients by advancing new medicines through its clinical development pipeline. Vanda utilizes modern technologies, including genetics and genomics, to inform its drug discovery and development process. Its portfolio includes commercialized products and therapies in development, with a focus on treatments for central nervous system disorders.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Vanda Pharmaceuticals Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vanda Pharmaceuticals Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vanda Pharmaceuticals Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Benitec Biopharma Inc. Logo
Develops ddRNAi gene therapies to silence genes causing chronic, life-threatening diseases.
United States of America BNTC
BeOne Medicines Ltd. Logo
Develops innovative and accessible cancer treatments for patients worldwide.
United States of America ONC
BGM Group Ltd. Logo
A pharma holding co. making APIs & TCM derivatives via bio-fermentation and extraction.
United States of America BGM
Bicara Therapeutics Inc. Logo
Developing first-in-class, dual-action bifunctional therapies for solid tumor patients.
United States of America BCAX
BICYCLE THERAPEUTICS PLC Logo
Developing novel bicyclic peptide medicines to precisely target hard-to-treat cancers.
United States of America BCYC
BIFIDO. Co. Ltd Logo
Biotech firm specializing in microbiome R&D for functional foods and cosmeceuticals.
South Korea 238200
BioAge Labs, Inc. Logo
Develops therapies for metabolic diseases like obesity by targeting the biology of human aging.
United States of America BIOA
BioArctic Logo
Develops treatments and diagnostics for neurodegenerative disorders like Alzheimer's and Parkinson's.
Sweden BIOA
BioAtla, Inc. Logo
Developing safer, conditionally active antibody therapies for solid tumor cancers.
United States of America BCAB
BioCardia, Inc. Logo
Developing regenerative cell therapies for cardiovascular and pulmonary diseases.
United States of America BCDA

Talk to a Data Expert

Have a question? We'll get back to you promptly.